AD and T2D share molecular, biochemical, pathophysiological and metabolic dysfunctions, such as peripheral and central insulin resistance, chronic low grade inflammation, enhanced oxidative stress, DNA damage, mitochondrial dysfunction and reduced insulin secretion. This evidence concerns the gene INS and type 2 diabetes mellitus.